Identification of human flavin-containing monooxygenase 3 substrates by a colorimetric screening assay

被引:11
作者
Catucci, Gianluca [1 ]
Polignano, Isabelle [1 ]
Cusumano, Debora [1 ]
Medana, Claudio [2 ]
Gilardi, Gianfranco [1 ]
Sadeghi, Sheila J. [1 ]
机构
[1] Univ Torino, Dept Life Sci & Syst Biol, Via Accademia Albertina 13, I-10123 Turin, Italy
[2] Univ Torino, Dept Mol Biotechnol & Hlth Sci, I-10125 Turin, Italy
关键词
FMO; Flavoprotein; HTS; Tamoxifen; Doping drugs; Mass spectrometry; METABOLISM; FMO;
D O I
10.1016/j.ab.2017.01.024
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Human hepatic flavin-containing monooxygenase 3 is a phase I drug-metabolizing enzyme that is responsible for the oxidation of a variety of drugs and xenobiotics. This work reports on a high throughput rapid colorimetric assay for the screening of substrates or inhibitors of this enzyme. The method is based on the competition of two substrates for access to the active site of hFMO3 whereby the enzymatic product of the first drug converts nitro-5-thiobenzoate (TNB, yellow) to 5,5 '-dithiobis (2-nitrobenzoate) (DTNB, colourless). Upon addition of a competing substrate, the amount of detected DNTB is decreased. The assay is validated testing three known substrates of hFM03, namely benzydamine, tozasertib and tamoxifen. The latter drugs resulted in 41%-55% inhibition. In addition, two other drugs also classified as doping drugs, selegiline and clomiphene, were selected based on their chemical structure similarity to known substrates of hFMO3. These drugs showed 21% and 60% inhibition in the colorimetric assay and therefore were proven to be hFMO3 substrates. LC-MS was used to confirm their N-oxide products. Further characterisation of these newly identified hFM03 substrates was performed determining their Km and k(cat) values that resulted to be 314 mu M and 1.4 min(-1) for selegiline and, 18 mu M and 0.1 min(-1) for clomiphene. This method paves the way for a rapid automated high throughput screening of nitrogen-containing compounds as substrates/inhibitors of hFM03. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:46 / 52
页数:7
相关论文
共 50 条
  • [41] Actions of ethnobotanically selected Cree anti-diabetic plants on human cytochrome P450 isoforms and flavin-containing monooxygenase 3
    Tam, Teresa W.
    Liu, Rui
    Arnason, John T.
    Krantis, Anthony
    Staines, William A.
    Haddad, Pierre S.
    Foster, Brian C.
    JOURNAL OF ETHNOPHARMACOLOGY, 2009, 126 (01) : 119 - 126
  • [42] A bird's-eye view: exploration of the flavin-containing monooxygenase superfamily in common wheat
    Sun, Sherry
    Bakkeren, Guus
    FRONTIERS IN PLANT SCIENCE, 2024, 15
  • [43] C-terminal truncation of rabbit flavin-containing monooxygenase isoform 2 enhances solubility
    Krueger, SK
    Siddens, LK
    Henderson, MC
    VanDyke, JE
    Karplus, PA
    Pereira, CB
    Williams, DE
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2006, 450 (02) : 149 - 156
  • [44] Inter-individual Variation in Flavin-containing Monooxygenase 3 in Livers from Japanese: Correlation with Hepatic Transcription Factors
    Nagashima, Satomi
    Shimizu, Makiko
    Yano, Hiroshi
    Murayama, Norie
    Kumai, Toshio
    Kobayashi, Shinichi
    Guengerich, F. Peter
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2009, 24 (03) : 218 - 225
  • [45] Developmental and tissue-specific expression of human flavin-containing monooxygenases 1 and 3
    Hines, Ronald N.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (01) : 41 - 49
  • [46] A series of simple detection systems for genetic variants of flavin-containing monooxygenase 3 (FMO3) with impaired function in Japanese subjects
    Shimizu, Makiko
    Mizugaki, Ami
    Koibuchi, Natsumi
    Sango, Haruna
    Uenuma, Yumi
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2021, 41
  • [47] Development of a physiologically based pharmacokinetic model to predict the effects of flavin-containing monooxygenase 3 (FMO3) polymorphisms on itopride exposure
    Zhou, Wangda
    Humphries, Helen
    Neuhoff, Sibylle
    Gardner, Iain
    Masson, Eric
    Al-Huniti, Nidal
    Zhou, Diansong
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2017, 38 (06) : 389 - 393
  • [48] A family study of compound variants of flavin-containing monooxygenase 3 (FMO3) in Japanese subjects found by urinary phenotyping for trimethylaminuria
    Shimizu, Makiko
    Yamamoto, Akane
    Makiguchi, Miaki
    Shimamura, Erika
    Yokota, Yuka
    Harano, Mizuki
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2023, 50
  • [49] Structure-Based Redesign of a Self-Sufficient Flavin-Containing Monooxygenase towards Indigo Production
    Loncar, Nikola
    van Beek, Hugo L.
    Fraaije, Marco W.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (24)
  • [50] Flavin-containing monooxygenase 1-catalysed N,N-dimethylamphetamine N-oxidation
    Lee, S. K.
    Kang, M. J.
    Jin, C.
    In, M. K.
    Kim, D. -H.
    Yoo, H. H.
    XENOBIOTICA, 2009, 39 (09) : 680 - 686